 | • レポートコード：GIR-107A14503 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ナノ構造医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ナノ構造医薬品の種類別市場規模（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロ乳状液・ナノ乳状液、ナノ懸濁液）、用途別市場規模（がん・腫瘍、自己免疫疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ナノ構造医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Roche、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson、Celgene、Novavax、Stryker、Gilead Sciences、OSI Pharmaceuticals、Kadmon Pharmaceuticals、Samyang Biopharm、Mitsubishi Pharma、Kaken Pharmaceutical、Selecta Biosciences、Par Pharmaceutical、Cerulean Pharma、Navidea Biopharmaceuticals、Lummy ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロ乳状液・ナノ乳状液、ナノ懸濁液 ・用途別分析2016年-2026年：がん・腫瘍、自己免疫疾患 ・ナノ構造医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ナノ構造医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ナノ構造医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ナノ構造医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ナノ構造医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Nanostructured Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nanostructured Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Nanostructured Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Nanostructured Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
Market segment by Application can be divided into
Cancer and Tumors
Autoimmune Disorders
The key market players for global Nanostructured Drug market are listed below:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Nanostructured Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nanostructured Drug, with price, sales, revenue and global market share of Nanostructured Drug from 2019 to 2021.
Chapter 3, the Nanostructured Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nanostructured Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Nanostructured Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Nanostructured Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Nanostructured Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nanostructured Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid lipid Nanoparticles
1.2.5 Microemulsion and Nanoemulsion
1.2.6 Nanosuspension
1.3 Market Analysis by Application
1.3.1 Overview: Global Nanostructured Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 Global Nanostructured Drug Market Size & Forecast
1.4.1 Global Nanostructured Drug Sales in Value (2016-2026))
1.4.2 Global Nanostructured Drug Sales in Volume (2016-2026)
1.4.3 Global Nanostructured Drug Price by Type (2016-2026) & (USD/MT)
1.5 Global Nanostructured Drug Production Capacity Analysis
1.5.1 Global Nanostructured Drug Total Production Capacity (2016-2026)
1.5.2 Global Nanostructured Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nanostructured Drug Market Drivers
1.6.2 Nanostructured Drug Market Restraints
1.6.3 Nanostructured Drug Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Nanostructured Drug Product and Services
2.1.4 Merck Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Nanostructured Drug Product and Services
2.2.4 Pfizer Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Nanostructured Drug Product and Services
2.3.4 Novartis Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Nanostructured Drug Product and Services
2.4.4 Abbott Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Nanostructured Drug Product and Services
2.5.4 GlaxoSmithKline Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Nanostructured Drug Product and Services
2.6.4 Roche Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Nanostructured Drug Product and Services
2.7.4 Sanofi Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Nanostructured Drug Product and Services
2.8.4 Eli Lilly Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Astrazeneca
2.9.1 Astrazeneca Details
2.9.2 Astrazeneca Major Business
2.9.3 Astrazeneca Nanostructured Drug Product and Services
2.9.4 Astrazeneca Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Nanostructured Drug Product and Services
2.10.4 Johnson & Johnson Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Celgene
2.11.1 Celgene Details
2.11.2 Celgene Major Business
2.11.3 Celgene Nanostructured Drug Product and Services
2.11.4 Celgene Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Novavax
2.12.1 Novavax Details
2.12.2 Novavax Major Business
2.12.3 Novavax Nanostructured Drug Product and Services
2.12.4 Novavax Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Stryker
2.13.1 Stryker Details
2.13.2 Stryker Major Business
2.13.3 Stryker Nanostructured Drug Product and Services
2.13.4 Stryker Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Gilead Sciences
2.14.1 Gilead Sciences Details
2.14.2 Gilead Sciences Major Business
2.14.3 Gilead Sciences Nanostructured Drug Product and Services
2.14.4 Gilead Sciences Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 OSI Pharmaceuticals
2.15.1 OSI Pharmaceuticals Details
2.15.2 OSI Pharmaceuticals Major Business
2.15.3 OSI Pharmaceuticals Nanostructured Drug Product and Services
2.15.4 OSI Pharmaceuticals Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Kadmon Pharmaceuticals
2.16.1 Kadmon Pharmaceuticals Details
2.16.2 Kadmon Pharmaceuticals Major Business
2.16.3 Kadmon Pharmaceuticals Nanostructured Drug Product and Services
2.16.4 Kadmon Pharmaceuticals Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Samyang Biopharm
2.17.1 Samyang Biopharm Details
2.17.2 Samyang Biopharm Major Business
2.17.3 Samyang Biopharm Nanostructured Drug Product and Services
2.17.4 Samyang Biopharm Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Mitsubishi Pharma
2.18.1 Mitsubishi Pharma Details
2.18.2 Mitsubishi Pharma Major Business
2.18.3 Mitsubishi Pharma Nanostructured Drug Product and Services
2.18.4 Mitsubishi Pharma Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Kaken Pharmaceutical
2.19.1 Kaken Pharmaceutical Details
2.19.2 Kaken Pharmaceutical Major Business
2.19.3 Kaken Pharmaceutical Nanostructured Drug Product and Services
2.19.4 Kaken Pharmaceutical Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Selecta Biosciences
2.20.1 Selecta Biosciences Details
2.20.2 Selecta Biosciences Major Business
2.20.3 Selecta Biosciences Nanostructured Drug Product and Services
2.20.4 Selecta Biosciences Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Par Pharmaceutical
2.21.1 Par Pharmaceutical Details
2.21.2 Par Pharmaceutical Major Business
2.21.3 Par Pharmaceutical Nanostructured Drug Product and Services
2.21.4 Par Pharmaceutical Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Cerulean Pharma
2.22.1 Cerulean Pharma Details
2.22.2 Cerulean Pharma Major Business
2.22.3 Cerulean Pharma Nanostructured Drug Product and Services
2.22.4 Cerulean Pharma Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Navidea Biopharmaceuticals
2.23.1 Navidea Biopharmaceuticals Details
2.23.2 Navidea Biopharmaceuticals Major Business
2.23.3 Navidea Biopharmaceuticals Nanostructured Drug Product and Services
2.23.4 Navidea Biopharmaceuticals Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Lummy
2.24.1 Lummy Details
2.24.2 Lummy Major Business
2.24.3 Lummy Nanostructured Drug Product and Services
2.24.4 Lummy Nanostructured Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Nanostructured Drug Sales by Manufacturer
3.1 Global Nanostructured Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Nanostructured Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Nanostructured Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Nanostructured Drug Manufacturer Market Share
3.4.2 Top 6 Nanostructured Drug Manufacturer Market Share
3.5 Global Nanostructured Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Nanostructured Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nanostructured Drug Market Size by Region
4.1.1 Global Nanostructured Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Nanostructured Drug Revenue by Region (2016-2026)
4.2 North America Nanostructured Drug Revenue (2016-2026)
4.3 Europe Nanostructured Drug Revenue (2016-2026)
4.4 Asia-Pacific Nanostructured Drug Revenue (2016-2026)
4.5 South America Nanostructured Drug Revenue (2016-2026)
4.6 Middle East and Africa Nanostructured Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Nanostructured Drug Sales in Volume by Type (2016-2026)
5.2 Global Nanostructured Drug Revenue by Type (2016-2026)
5.3 Global Nanostructured Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Nanostructured Drug Sales in Volume by Application (2016-2026)
6.2 Global Nanostructured Drug Revenue by Application (2016-2026)
6.3 Global Nanostructured Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Nanostructured Drug Sales by Type (2016-2026)
7.2 North America Nanostructured Drug Sales by Application (2016-2026)
7.3 North America Nanostructured Drug Market Size by Country
7.3.1 North America Nanostructured Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Nanostructured Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Nanostructured Drug Sales by Type (2016-2026)
8.2 Europe Nanostructured Drug Sales by Application (2016-2026)
8.3 Europe Nanostructured Drug Market Size by Country
8.3.1 Europe Nanostructured Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Nanostructured Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Nanostructured Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Nanostructured Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Nanostructured Drug Market Size by Region
9.3.1 Asia-Pacific Nanostructured Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Nanostructured Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Nanostructured Drug Sales by Type (2016-2026)
10.2 South America Nanostructured Drug Sales by Application (2016-2026)
10.3 South America Nanostructured Drug Market Size by Country
10.3.1 South America Nanostructured Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Nanostructured Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nanostructured Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Nanostructured Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Nanostructured Drug Market Size by Country
11.3.1 Middle East & Africa Nanostructured Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Nanostructured Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Nanostructured Drug Typical Distributors
12.3 Nanostructured Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Nanostructured Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Nanostructured Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Nanostructured Drug Product and Services
Table 6. Merck Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Nanostructured Drug Product and Services
Table 10. Pfizer Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Nanostructured Drug Product and Services
Table 14. Novartis Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Nanostructured Drug Product and Services
Table 18. Abbott Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Nanostructured Drug Product and Services
Table 22. GlaxoSmithKline Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Roche Basic Information, Manufacturing Base and Competitors
Table 24. Roche Major Business
Table 25. Roche Nanostructured Drug Product and Services
Table 26. Roche Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Nanostructured Drug Product and Services
Table 30. Sanofi Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Major Business
Table 33. Eli Lilly Nanostructured Drug Product and Services
Table 34. Eli Lilly Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 36. Astrazeneca Major Business
Table 37. Astrazeneca Nanostructured Drug Product and Services
Table 38. Astrazeneca Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 40. Johnson & Johnson Major Business
Table 41. Johnson & Johnson Nanostructured Drug Product and Services
Table 42. Johnson & Johnson Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Celgene Basic Information, Manufacturing Base and Competitors
Table 44. Celgene Major Business
Table 45. Celgene Nanostructured Drug Product and Services
Table 46. Celgene Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Novavax Basic Information, Manufacturing Base and Competitors
Table 48. Novavax Major Business
Table 49. Novavax Nanostructured Drug Product and Services
Table 50. Novavax Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Stryker Basic Information, Manufacturing Base and Competitors
Table 52. Stryker Major Business
Table 53. Stryker Nanostructured Drug Product and Services
Table 54. Stryker Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 56. Gilead Sciences Major Business
Table 57. Gilead Sciences Nanostructured Drug Product and Services
Table 58. Gilead Sciences Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. OSI Pharmaceuticals Major Business
Table 61. OSI Pharmaceuticals Nanostructured Drug Product and Services
Table 62. OSI Pharmaceuticals Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Kadmon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Kadmon Pharmaceuticals Major Business
Table 65. Kadmon Pharmaceuticals Nanostructured Drug Product and Services
Table 66. Kadmon Pharmaceuticals Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Samyang Biopharm Basic Information, Manufacturing Base and Competitors
Table 68. Samyang Biopharm Major Business
Table 69. Samyang Biopharm Nanostructured Drug Product and Services
Table 70. Samyang Biopharm Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Mitsubishi Pharma Basic Information, Manufacturing Base and Competitors
Table 72. Mitsubishi Pharma Major Business
Table 73. Mitsubishi Pharma Nanostructured Drug Product and Services
Table 74. Mitsubishi Pharma Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Kaken Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Kaken Pharmaceutical Major Business
Table 77. Kaken Pharmaceutical Nanostructured Drug Product and Services
Table 78. Kaken Pharmaceutical Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Selecta Biosciences Basic Information, Manufacturing Base and Competitors
Table 80. Selecta Biosciences Major Business
Table 81. Selecta Biosciences Nanostructured Drug Product and Services
Table 82. Selecta Biosciences Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. Par Pharmaceutical Major Business
Table 85. Par Pharmaceutical Nanostructured Drug Product and Services
Table 86. Par Pharmaceutical Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Cerulean Pharma Basic Information, Manufacturing Base and Competitors
Table 88. Cerulean Pharma Major Business
Table 89. Cerulean Pharma Nanostructured Drug Product and Services
Table 90. Cerulean Pharma Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Navidea Biopharmaceuticals Major Business
Table 93. Navidea Biopharmaceuticals Nanostructured Drug Product and Services
Table 94. Navidea Biopharmaceuticals Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Lummy Basic Information, Manufacturing Base and Competitors
Table 96. Lummy Major Business
Table 97. Lummy Nanostructured Drug Product and Services
Table 98. Lummy Nanostructured Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Global Nanostructured Drug Sales by Manufacturer (2019-2021e) & (K MT)
Table 100. Global Nanostructured Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 101. Market Position of Manufacturers in Nanostructured Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 102. Global Nanostructured Drug Production Capacity by Company, (K MT): 2020 VS 2021
Table 103. Head Office and Nanostructured Drug Production Site of Key Manufacturer
Table 104. Nanostructured Drug New Entrant and Capacity Expansion Plans
Table 105. Nanostructured Drug Mergers & Acquisitions in the Past Five Years
Table 106. Global Nanostructured Drug Sales by Region (2016-2021e) & (K MT)
Table 107. Global Nanostructured Drug Sales by Region (2021-2026) & (K MT)
Table 108. Global Nanostructured Drug Revenue by Region (2016-2021e) & (USD Million)
Table 109. Global Nanostructured Drug Revenue by Region (2021-2026) & (USD Million)
Table 110. Global Nanostructured Drug Sales by Type (2016-2021e) & (K MT)
Table 111. Global Nanostructured Drug Sales by Type (2021-2026) & (K MT)
Table 112. Global Nanostructured Drug Revenue by Type (2016-2021e) & (USD Million)
Table 113. Global Nanostructured Drug Revenue by Type (2021-2026) & (USD Million)
Table 114. Global Nanostructured Drug Price by Type (2016-2021e) & (USD/MT)
Table 115. Global Nanostructured Drug Price by Type (2021-2026) & (USD/MT)
Table 116. Global Nanostructured Drug Sales by Application (2016-2021e) & (K MT)
Table 117. Global Nanostructured Drug Sales by Application (2021-2026) & (K MT)
Table 118. Global Nanostructured Drug Revenue by Application (2016-2021e) & (USD Million)
Table 119. Global Nanostructured Drug Revenue by Application (2021-2026) & (USD Million)
Table 120. Global Nanostructured Drug Price by Application (2016-2021e) & (USD/MT)
Table 121. Global Nanostructured Drug Price by Application (2021-2026) & (USD/MT)
Table 122. North America Nanostructured Drug Sales by Country (2016-2021e) & (K MT)
Table 123. North America Nanostructured Drug Sales by Country (2021-2026) & (K MT)
Table 124. North America Nanostructured Drug Revenue by Country (2016-2021e) & (USD Million)
Table 125. North America Nanostructured Drug Revenue by Country (2021-2026) & (USD Million)
Table 126. North America Nanostructured Drug Sales by Type (2016-2021e) & (K MT)
Table 127. North America Nanostructured Drug Sales by Type (2021-2026) & (K MT)
Table 128. North America Nanostructured Drug Sales by Application (2016-2021e) & (K MT)
Table 129. North America Nanostructured Drug Sales by Application (2021-2026) & (K MT)
Table 130. Europe Nanostructured Drug Sales by Country (2016-2021e) & (K MT)
Table 131. Europe Nanostructured Drug Sales by Country (2021-2026) & (K MT)
Table 132. Europe Nanostructured Drug Revenue by Country (2016-2021e) & (USD Million)
Table 133. Europe Nanostructured Drug Revenue by Country (2021-2026) & (USD Million)
Table 134. Europe Nanostructured Drug Sales by Type (2016-2021e) & (K MT)
Table 135. Europe Nanostructured Drug Sales by Type (2021-2026) & (K MT)
Table 136. Europe Nanostructured Drug Sales by Application (2016-2021e) & (K MT)
Table 137. Europe Nanostructured Drug Sales by Application (2021-2026) & (K MT)
Table 138. Asia-Pacific Nanostructured Drug Sales by Region (2016-2021e) & (K MT)
Table 139. Asia-Pacific Nanostructured Drug Sales by Region (2021-2026) & (K MT)
Table 140. Asia-Pacific Nanostructured Drug Revenue by Region (2016-2021e) & (USD Million)
Table 141. Asia-Pacific Nanostructured Drug Revenue by Region (2021-2026) & (USD Million)
Table 142. Asia-Pacific Nanostructured Drug Sales by Type (2016-2021e) & (K MT)
Table 143. Asia-Pacific Nanostructured Drug Sales by Type (2021-2026) & (K MT)
Table 144. Asia-Pacific Nanostructured Drug Sales by Application (2016-2021e) & (K MT)
Table 145. Asia-Pacific Nanostructured Drug Sales by Application (2021-2026) & (K MT)
Table 146. South America Nanostructured Drug Sales by Country (2016-2021e) & (K MT)
Table 147. South America Nanostructured Drug Sales by Country (2021-2026) & (K MT)
Table 148. South America Nanostructured Drug Revenue by Country (2016-2021e) & (USD Million)
Table 149. South America Nanostructured Drug Revenue by Country (2021-2026) & (USD Million)
Table 150. South America Nanostructured Drug Sales by Type (2016-2021e) & (K MT)
Table 151. South America Nanostructured Drug Sales by Type (2021-2026) & (K MT)
Table 152. South America Nanostructured Drug Sales by Application (2016-2021e) & (K MT)
Table 153. South America Nanostructured Drug Sales by Application (2021-2026) & (K MT)
Table 154. Middle East & Africa Nanostructured Drug Sales by Country (2016-2021e) & (K MT)
Table 155. Middle East & Africa Nanostructured Drug Sales by Country (2021-2026) & (K MT)
Table 156. Middle East & Africa Nanostructured Drug Revenue by Country (2016-2021e) & (USD Million)
Table 157. Middle East & Africa Nanostructured Drug Revenue by Country (2021-2026) & (USD Million)
Table 158. Middle East & Africa Nanostructured Drug Sales by Type (2016-2021e) & (K MT)
Table 159. Middle East & Africa Nanostructured Drug Sales by Type (2021-2026) & (K MT)
Table 160. Middle East & Africa Nanostructured Drug Sales by Application (2016-2021e) & (K MT)
Table 161. Middle East & Africa Nanostructured Drug Sales by Application (2021-2026) & (K MT)
Table 162. Direct Channel Pros & Cons
Table 163. Indirect Channel Pros & Cons
Table 164. Nanostructured Drug Typical Distributors
Table 165. Nanostructured Drug Typical Customers
List of Figures
Figure 1. Nanostructured Drug Picture
Figure 2. Global Nanostructured Drug Sales Market Share by Type in 2020
Figure 3. Liposomes
Figure 4. Polymeric Micelles
Figure 5. Solid lipid Nanoparticles
Figure 6. Microemulsion and Nanoemulsion
Figure 7. Nanosuspension
Figure 8. Global Nanostructured Drug Sales Market Share by Application in 2020
Figure 9. Cancer and Tumors
Figure 10. Autoimmune Disorders
Figure 11. Global Nanostructured Drug Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Nanostructured Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Nanostructured Drug Sales (2016-2026) & (K MT)
Figure 14. Global Nanostructured Drug Price by Type (2016-2026) & (USD/MT)
Figure 15. Global Nanostructured Drug Production Capacity (2016-2026) & (K MT)
Figure 16. Global Nanostructured Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Nanostructured Drug Market Drivers
Figure 18. Nanostructured Drug Market Restraints
Figure 19. Nanostructured Drug Market Trends
Figure 20. Global Nanostructured Drug Sales Market Share by Manufacturer in 2020
Figure 21. Global Nanostructured Drug Revenue Market Share by Manufacturer in 2020
Figure 22. Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Nanostructured Drug Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Nanostructured Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Nanostructured Drug Sales Market Share by Region (2016-2026)
Figure 26. Global Nanostructured Drug Revenue Market Share by Region (2016-2026)
Figure 27. North America Nanostructured Drug Revenue (2016-2026) & (USD Million)
Figure 28. Europe Nanostructured Drug Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Nanostructured Drug Revenue (2016-2026) & (USD Million)
Figure 30. South America Nanostructured Drug Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Nanostructured Drug Revenue (2016-2026) & (USD Million)
Figure 32. Global Nanostructured Drug Sales Market Share by Type (2016-2026)
Figure 33. Global Nanostructured Drug Revenue Market Share by Type (2016-2026)
Figure 34. Global Nanostructured Drug Price by Type (2016-2026) & (USD/MT)
Figure 35. Global Nanostructured Drug Sales Market Share by Application (2016-2026)
Figure 36. Global Nanostructured Drug Revenue Market Share by Application (2016-2026)
Figure 37. Global Nanostructured Drug Price by Application (2016-2026) & (USD/MT)
Figure 38. North America Nanostructured Drug Sales Market Share by Type (2016-2026)
Figure 39. North America Nanostructured Drug Sales Market Share by Application (2016-2026)
Figure 40. North America Nanostructured Drug Sales Market Share by Country (2016-2026)
Figure 41. North America Nanostructured Drug Revenue Market Share by Country (2016-2026)
Figure 42. United States Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Nanostructured Drug Sales Market Share by Type (2016-2026)
Figure 46. Europe Nanostructured Drug Sales Market Share by Application (2016-2026)
Figure 47. Europe Nanostructured Drug Sales Market Share by Country (2016-2026)
Figure 48. Europe Nanostructured Drug Revenue Market Share by Country (2016-2026)
Figure 49. Germany Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Nanostructured Drug Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Nanostructured Drug Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Nanostructured Drug Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Nanostructured Drug Revenue Market Share by Region (2016-2026)
Figure 58. China Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Nanostructured Drug Sales Market Share by Type (2016-2026)
Figure 65. South America Nanostructured Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Nanostructured Drug Sales Market Share by Country (2016-2026)
Figure 67. South America Nanostructured Drug Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Nanostructured Drug Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Nanostructured Drug Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Nanostructured Drug Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Nanostructured Drug Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Nanostructured Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の金属・金属酸化物ナノ粒子市場 2021：企業別、地域別、種類・用途別 The Metal & Metal Oxide Nanoparticles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 世界のがん生物毒素薬市場 2021：企業別、地域別、種類・用途別 The Cancer Biological Toxins Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の乳がん診断・薬物技術市場 2021：企業別、地域別、種類・用途別 The Breast Cancer Diagnostic and Drug Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 世界のナノ金属酸化物（NMO）市場 2021：企業別、地域別、種類・用途別 The Nano Metal Oxide (NMO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界のグラフェンナノパウダー市場 2021：企業別、地域別、種類・用途別 The Graphene Nanopowder market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…